Stereotaxis (STXS) Change in Receivables (2010 - 2026)
Stereotaxis (STXS) posted quarterly Change in Receivables of -$543000.0 for Q1 2026, down 208.6% year-over-year from $500000.0 in Q1 2025, and down 205.64% quarter-over-quarter from $514000.0 in Q4 2025.
Stereotaxis (STXS) Change in Receivables (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Change in Receivables for 17 consecutive years, with -$543000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 208.6% year-over-year to -$543000.0; the TTM figure through Mar 2026 stood at $980000.0 (up 404.35% YoY), while the FY2025 annual figure was $2.0 million, up 392.76% from the prior year.
- Change in Receivables eased to -$543000.0 in Q1 2026 per STXS's latest filing, from $514000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $4.4 million in Q3 2024 and bottomed at -$4.1 million in Q4 2024.
- Historically, Change in Receivables has averaged -$46764.7 across 5 years, with a median of $13000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Receivables plunged 11053.85% — and 2024, when it jumped 417.44%.
- Stereotaxis' Change in Receivables stood at $13000.0 in 2022, then slumped by 11053.85% to -$1.4 million in 2023, then slumped by 187.36% to -$4.1 million in 2024, then soared by 112.56% to $514000.0 in 2025, then slumped by 205.64% to -$543000.0 in 2026.
- Business Quant data shows STXS's Change in Receivables at -$543000.0 in Q1 2026, $514000.0 in Q4 2025, and $940000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | -543,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -543,000.00 |
| Mar 31, 2026 | -543,000.00 |
| Dec 31, 2025 | 514,000.00 |
| Dec 31, 2025 | 514,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Jun 30, 2025 | 69,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | -4.09 Mn |
| Dec 31, 2024 | -4.09 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | 131,000.00 |
| Mar 31, 2024 | 131,000.00 |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |